Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

The Clinical Pictures of Autoimmune Hemolytic Anemia.

Packman CH.

Transfus Med Hemother. 2015 Sep;42(5):317-24. doi: 10.1159/000440656. Epub 2015 Sep 11. Review.

2.

Hemolytic anemia due to warm autoantibodies: new and traditional approaches to treatment.

Packman CH.

Clin Adv Hematol Oncol. 2008 Oct;6(10):739-41. No abstract available.

PMID:
18997664
3.

Hemolytic anemia due to warm autoantibodies.

Packman CH.

Blood Rev. 2008 Jan;22(1):17-31. Epub 2007 Sep 27. Review.

PMID:
17904259
4.

Randomized controlled trial of pilocarpine hydrochloride for the moderation of oral mucositis during autologous blood stem cell transplantation.

Lockhart PB, Brennan MT, Kent ML, Packman CH, Norton HJ, Fox PC, Frenette G.

Bone Marrow Transplant. 2005 Apr;35(7):713-20.

PMID:
15696181
5.

The spherocytic haemolytic anaemias.

Packman CH.

Br J Haematol. 2001 Mar;112(4):888-99. Review. No abstract available.

PMID:
11298583
6.

Treatment of chronic myelogenous leukemia with autologous bone marrow transplantation followed by roquinimex.

Rowe JM, Rapoport AP, Ryan DH, Nilsson BI, Duerst RE, Packman CH, Abboud CN, DiPersio JF, Linder T, Wang N, Simonsson B, Liesveld JL.

Bone Marrow Transplant. 1999 Nov;24(10):1057-63.

7.

Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants.

Rapoport AP, Miller Watelet LF, Linder T, Eberly S, Raubertas RF, Lipp J, Duerst R, Abboud CN, Constine L, Andrews J, Etter MA, Spear L, Powley E, Packman CH, Rowe JM, Schwertschlag U, Bedrosian C, Liesveld JL.

J Clin Oncol. 1999 Aug;17(8):2446-53.

PMID:
10561308
8.

Autotransplantation for relapsed or refractory Hodgkin's disease: long-term follow-up and analysis of prognostic factors.

Lancet JE, Rapoport AP, Brasacchio R, Eberly S, Raubertas RF, Linder T, Muhs A, Duerst RE, Abboud CN, Packman CH, DiPersio JF, Constine LS, Rowe JM, Liesveld JL.

Bone Marrow Transplant. 1998 Aug;22(3):265-71.

9.

Pathogenesis and management of paroxysmal nocturnal haemoglobinuria.

Packman CH.

Blood Rev. 1998 Mar;12(1):1-11. Review.

PMID:
9597193
10.

Treatment of multifocal lymphoma of bone with intensified ProMACE-CytaBOM chemotherapy and involved field radiotherapy.

Rapoport AP, Constine LS, Packman CH, Rosier RN, O'Keefe R, Hicks DG, Rubin SJ, Rowe JM.

Am J Hematol. 1998 May;58(1):1-7.

11.

Autotransplantation for relapsed or refractory non-Hodgkin's lymphoma (NHL): long-term follow-up and analysis of prognostic factors.

Rapoport AP, Lifton R, Constine LS, Duerst RE, Abboud CN, Liesveld JL, Packman CH, Eberly S, Raubertas RF, Martin BA, Flesher WR, Kouides PA, DiPersio JF, Rowe JM.

Bone Marrow Transplant. 1997 May;19(9):883-90.

12.

Treatment of the neutropenia of Felty syndrome.

Rashba EJ, Rowe JM, Packman CH.

Blood Rev. 1996 Sep;10(3):177-84. Review.

PMID:
8932830
13.

Changes in cytoskeletal actin content, F-actin distribution, and surface morphology during HL-60 cell volume regulation.

Hallows KR, Law FY, Packman CH, Knauf PA.

J Cell Physiol. 1996 Apr;167(1):60-71.

PMID:
8698841
15.

Functional characteristics of mature granulocytes in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid.

Sham RL, Phatak PD, Belanger KA, Braggins C, Packman CH.

Leuk Res. 1995 Aug;19(8):505-11.

PMID:
7544848
16.

Patients > or = age 40 years undergoing autologous or allogeneic BMT have regimen-related mortality rates and event-free survivals comparable to patients < age 40 years.

Rapoport AP, DiPersio JF, Martin BA, Duerst RE, Kouides PA, Liesveld JL, Abboud CN, Packman CH, Eberly SW, Sherman M, et al.

Bone Marrow Transplant. 1995 Apr;15(4):523-30.

PMID:
7655376
17.
18.

The Rochester practice-based experience. An experiment in medical education.

Packman CH, Krackov SK, Groff GD, Cohen J.

Arch Intern Med. 1994 Jun 13;154(11):1253-60.

PMID:
8203992
19.
20.

One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome.

Rapoport AP, Rowe JM, Kouides PA, Duerst RA, Abboud CN, Liesveld JL, Packman CH, Eberly S, Sherman M, Tanner MA, et al.

J Clin Oncol. 1993 Dec;11(12):2351-61.

PMID:
8246024
21.

The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.

Freeman SM, Abboud CN, Whartenby KA, Packman CH, Koeplin DS, Moolten FL, Abraham GN.

Cancer Res. 1993 Nov 1;53(21):5274-83.

22.

Signal pathway regulation of interleukin-8-induced actin polymerization in neutrophils.

Sham RL, Phatak PD, Ihne TP, Abboud CN, Packman CH.

Blood. 1993 Oct 15;82(8):2546-51.

PMID:
8400301
23.

Acute cell volume changes in anisotonic media affect F-actin content of HL-60 cells.

Hallows KR, Packman CH, Knauf PA.

Am J Physiol. 1991 Dec;261(6 Pt 1):C1154-61. Erratum in: Am J Physiol 1995 Jun;268(6 Pt 3):section C followi. Am J Physiol 1995 Mar;268(3 Pt 1):section C following table of contents.

PMID:
1767817
24.

Cardiac arrest after autologous marrow infusion.

Rapoport AP, Rowe JM, Packman CH, Ginsberg SJ.

Bone Marrow Transplant. 1991 May;7(5):401-3.

PMID:
2070152
25.

Signal transduction and the regulation of actin conformation during myeloid maturation: studies in HL60 cells.

Sham RL, Packman CH, Abboud CN, Lichtman MA.

Blood. 1991 Jan 15;77(2):363-70.

PMID:
1985701
26.

Control of actin conformation in AML myeloblasts: the effects of bryostatin and TPA.

Sham RL, Packman CH, Abboud CN, Lichtman MA.

Leuk Res. 1990;14(10):863-8.

PMID:
2259224
27.

Activation of neutrophils: measurement of actin conformational changes by flow cytometry.

Packman CH, Lichtman MA.

Blood Cells. 1990;16(1):193-205; discussion 205-7. Review.

PMID:
2190647
28.

Protein kinase C modulates actin conformation in human T lymphocytes.

Phatak PD, Packman CH, Lichtman MA.

J Immunol. 1988 Nov 1;141(9):2929-34.

PMID:
3262672
29.

Aberrant immunoglobulin and c-myc gene rearrangements in patients with nonmalignant monoclonal cryoglobulinemia.

Perl A, Wang N, Williams JM, Hunt MJ, Rosenfeld SI, Condemi JJ, Packman CH, Abraham GN.

J Immunol. 1987 Nov 15;139(10):3512-20. Erratum in: J Immunol 1988 May 15;140(10):3694.

PMID:
3316385
30.

The effects of sulfhydryl inhibitors and cytochalasin on the cytoplasmic and cytoskeletal actin of human neutrophils.

Wallace PJ, Packman CH, Wersto RP, Lichtman MA.

J Cell Physiol. 1987 Aug;132(2):325-30.

PMID:
3624318
31.

Characterization of monoclonal IgG cryoglobulins: fine-structural and morphological analysis.

Podell DN, Packman CH, Maniloff J, Abraham GN.

Blood. 1987 Feb;69(2):677-81.

PMID:
3801676
32.

Maturation-associated changes in the peripheral cytoplasm of human neutrophils: a review.

Wallace PJ, Packman CH, Lichtman MA.

Exp Hematol. 1987 Jan;15(1):34-45. Review.

PMID:
3023123
33.
34.

Neutrophilic eccrine hidradenitis associated with Hodgkin's disease and chemotherapy. A case report.

Beutner KR, Packman CH, Markowitch W.

Arch Dermatol. 1986 Jul;122(7):809-11.

PMID:
2425751
35.
36.

Chemotactic peptide-induced changes in neutrophil actin conformation.

Wallace PJ, Wersto RP, Packman CH, Lichtman MA.

J Cell Biol. 1984 Sep;99(3):1060-5.

37.

Amino-sugars enhance recognition and phagocytosis of particles by human neutrophils.

Doolittle RL, Packman CH, Lichtman MA.

Blood. 1983 Sep;62(3):697-701.

PMID:
6411150
38.
39.

Evolution of acute leukemia in a renal transplant patient--? Relationship to azathioprine.

Hoy WE, Packman CH, Freeman RB.

Transplantation. 1982 Mar;33(3):331-3. No abstract available.

PMID:
7039043
40.

Attachment of particle-bound IgG and complement to human neutrophils.

Lawrence WD, Packman CH, Rowe JM, Lichtman MA.

Blood. 1981 Oct;58(4):772-81.

PMID:
7272507
41.

Complement lysis of human erythrocytes. III. Differing effectiveness of human and guinea pig C9 on normal and paroxysmal nocturnal hemoglobinuria cells.

Rosenfeld SI, Packman CH, Jenkins DE Jr, Countryman JK, Leddy JP.

J Immunol. 1980 Nov;125(5):2063-8. No abstract available.

PMID:
6776186
42.

Complement lysis of human erythrocytes. II. A unique interaction of human C8 and C9 with paroxysmal nocturnal hemoglobinuria erythrocytes.

Packman CH, Rosenfeld SI, Jenkins DE Jr, Leddy JP.

J Immunol. 1980 Jun;124(6):2818-23. No abstract available.

PMID:
7189536
43.

Complement lysis of human erythrocytes. Differeing susceptibility of two types of paroxysmal nocturnal hemoglobinuria cells to C5b-9.

Packman CH, Rosenfeld SI, Jenkins DE Jr, Thiem PA, Leddy JP.

J Clin Invest. 1979 Aug;64(2):428-33.

44.

Veno-occlusive disease of the liver after chemotherapy of acute leukemia. Report of two cases.

Griner PF, Elbadawi A, Packman CH.

Ann Intern Med. 1976 Nov;85(5):578-82.

PMID:
1068643
45.

Complement-induced ultrastructural membrane lesions: requirement for terminal components.

Packman CH, Rosenfeld SI, Weed RI, Leddy JP.

J Immunol. 1976 Nov;117(5 Pt.2):1883-9.

PMID:
993584

Supplemental Content

Loading ...
Support Center